Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

Study ID: NCT01668082
Start Date: 2009-08
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

surgical resection of a brain tumor

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Study ID: NCT05746182
Start Date: 2023-04-07
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Hereditary Cancer Panel

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Study ID: NCT03537482
Start Date: 2018-08-07
End Date: 2025-02-15
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

90

Intervention / Treatment

APG-2575

Sponsor

Ascentage Pharma Group Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies

Study ID: NCT05356182
Start Date: 2022-05-04
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Diet

Sponsor

State University of New York at Buffalo

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Study ID: NCT05789082
Start Date: 2023-06-20
End Date: 2027-05-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

240

Intervention / Treatment

Wallpaper

Pembrolizumab

Carboplatin

Cisplatin

Pemetrexed

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Study ID: NCT03546582
Start Date: 2018-11-14
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

Pembrolizumab

Stereotactic Body Radiation Therapy (SBRT)

Sponsor

RTOG Foundation, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Study ID: NCT06295965
Start Date: 2024-01-02
End Date: 2031-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Non-Interventional Study

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Study ID: NCT03568266
Start Date: 2018-05-22
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Biospecimen Collection

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

Study ID: NCT05488366
Start Date: 2022-08-03
End Date: 2025-08
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

12

Intervention / Treatment

Pembrolizumab

Radiation therapy

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Bladder Bank (a Prospective Banking Study)

Study ID: NCT06109857
Start Date: 2022-07-06
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list